1	Inhibidores	inhibidor	NCMP000	-	-	0-11	473_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
2	DPP4	DPP4		-	-	12-16	473_ANS_clinical_caseMIR	SENT1	-	-	-	-	-
3	.	.	Fp	-	-	16-17	473_ANS_clinical_caseMIR	SENT1	-	-	-	-	-

1	Análogos	análogo	AQ0MP0	-	-	0-8	473_ANS_clinical_caseMIR	SENT2	-	-	-	-	-
2	GLP1	GLP1		-	-	9-13	473_ANS_clinical_caseMIR	SENT2	-	-	-	-	-
3	.	.	Fp	-	-	13-14	473_ANS_clinical_caseMIR	SENT2	-	-	-	-	-

1	Insulina	insulina	NCFS000	C0650607_1	producto_1	0-8	473_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-	-	-	-
2	basal	basal	NC00SC0	C0650607_2	producto_2	9-14	473_ANS_clinical_caseMIR	SENT3	-	-	-	-	-
3	.	.	Fp	-	-	14-15	473_ANS_clinical_caseMIR	SENT3	-	-	-	-	-

1	lnhibidores	lnhibidores	NCMP000	-	-	0-11	473_ANS_clinical_caseMIR	SENT4	-	-	-	-	-
2	SGLT2	SGLT2		-	-	12-17	473_ANS_clinical_caseMIR	SENT4	-	-	-	-	-
3	.	.	Fp	-	-	17-18	473_ANS_clinical_caseMIR	SENT4	-	-	-	-	-

